Category: MassMEDIC 11th Annual Medtech Investors Conference
The Boston-based company's VeriCor monitor measures left ventricular end-diastolic pressure to help in the early detection of changes in intravascular volume.
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We're talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Navis Medical's variable control guidewire system is designed to replace multiple catheters and guidewires with a single device.
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We're talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Navis Medical's variable control guidewire system is designed to replace multiple catheters and guidewires with a single device.
Officers
Richard Ganz
The Melrose, Mass.-based firm is developing an emergency signaling device for sudden cardiac arrest.
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We're talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
OmniMedics, Melrose, Mass.
OmniMedics is developing a Band-Aid-sized emergency signaling device for sudden cardiac arrest.
Officers
Ron Greene, CEO
Jim Miraldi, COO &CFO
The Bryn Athyn, Pa.-based firm is developing a device that takes blood glucose measurements through the skin of the finger.
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We're talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Lightouch Medical is developing a device that takes blood glucose measurements through the skin of the finger.
Officers
Donald Schmucker, President & CEO
George Shaheen, VP
Joseph Chaiken, CSO
Paul Shaheen, Co-Founder & Director
Ralph Brill, Consultant
The Framingham, Mass.-based bladder device maker wins the first MedTech Ignite 10k Innovative Technology Competition at MassMEDIC's 11th Annual Medtech Investors Conference.
Solace Therapeutics capped a big week with a win at the MassMEDIC 11th Annual Medtech Investors Conference, landing the first MedTech Ignite 10k Innovative Technology Competition award.
The Framingham, Mass.-based medical device maker won CE Mark approval in the European Union Oct. 1 for its intravesical system to treat female stress urinary incontinence.
The Boston-based firm's BronchoGen device is designed to improve the reliability of diagnosing lung cancer.
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We're talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Allegro Diagnostics, Boston
Allegro Diagnostics' BronchoGen aims to improve the ability to diagnose lung cancer.
Officers
Dan Rippy, President & CEO
The Woburn, Mass.-based firm is developing an adhesive foam for lung-volume reduction treatments.
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We're talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Aeris is developing an adhesive foam for lung-volume reduction treatments.
Officers
David Dove, President & CEO
Edward Ingenito, CSO & Medical Director